HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Incidence and risk factors of retinopathy of prematurity in a tertiary care newborn unit in New Delhi.

AbstractBACKGROUND:
Retinopathy of prematurity (RoP) has become more common in developed countries with an improvement in survival of very premature infants. Though previously rare, it is likely to emerge as a major problem in India because of improving outcome of 'at-risk' preterm infants.
METHODS:
In a prospective study we estimated the incidence of RoP among at-risk neonates in a tertiary care unit. Infants with birth-weights of < 1500 g, gestation < 35 weeks and preterm neonates who required supplemental oxygen for > 24 hours were subjected to periodic ophthalmological evaluation for detection of RoP until full retinal vascularization occurred.
RESULTS:
Sixty-six eligible infants completed the full protocol during the 15-month study period. The incidence of RoP was 20% in the cohort and 27% among the very low birth-weight neonates. The incidence of threshold RoP was 7% in the cohort. The occurrence of RoP was inversely related to the gestation and birth-weight. RoP typically developed at the post-conceptional age of 32-35 weeks. Blood transfusion and clinical sepsis emerged as independent risk factors of RoP on step-wise logistic regression analysis. Cryotherapy undertaken in 5 cases (9 eyes) led to amelioration of the changes of RoP.
CONCLUSION:
The incidence of RoP in our neonates was lower than that reported from other centres. Blood transfusion and clinical sepsis are risk factors for RoP in our newborn infants.
AuthorsR Maheshwari, H Kumar, V K Paul, M Singh, A K Deorari, H K Tiwari
JournalThe National medical journal of India (Natl Med J India) 1996 Sep-Oct Vol. 9 Issue 5 Pg. 211-4 ISSN: 0970-258X [Print] India
PMID8937058 (Publication Type: Journal Article)
Topics
  • Humans
  • India (epidemiology)
  • Infant, Newborn
  • Prospective Studies
  • Retinopathy of Prematurity (complications, epidemiology)
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: